Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy

Allen, Wendy L.; Dunne, Philip D.; McDade, Simon; Scanlon, Enya; Loughrey, Maurice; Coleman, Helen G.; McCann, Christophe; McLaughlin, Kristy; Nemeth, Zsuzsanna; Syed, Najeeb Ashraf; Jithesh, Puthen Veettil; Arthur, Ken; Wilson, Richard; Coyle, Vicky M.; McArt, Darragh; Murray, Graeme L.; Samuel, Leslie; Nuciforo, Paolo; Jimenez, Jose; Argiles, Guillem; Dienstmann, Rodrigo; Tabernero, Josef; Picariello, Lucia; Messerini, Luca; Nobili, Stefania; Mini, Enrico; Sheahan, Kieran; Ryan, Elizabeth; Johnston, Patrick G.; Van Schaeybroeck, Sandra; Lawler, Mark; Longley, Daniel B.

Citation

Allen , W L , Dunne , P D , McDade , S , Scanlon , E , Loughrey , M , Coleman , H G , McCann , C , McLaughlin , K , Nemeth , Z , Syed , N A , Jithesh , P V , Arthur , K , Wilson , R , Coyle , V M , McArt , D , Murray , G L , Samuel , L , Nuciforo , P , Jimenez , J , Argiles , G , Dienstmann , R , Tabernero , J , Picariello , L , Messerini , L , Nobili , S , Mini , E , Sheahan , K , Ryan , E , Johnston , P G , Van Schaeybroeck , S , Lawler , M & Longley , D B 2018 , ' Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy ' , JCO Precision Oncology , vol. 2 , pp. 1-15 . https://doi.org/10.1200/PO.17.00241